CD19 and acute lymphoblastic leukemia: Shortly thereafter, CD19-CAR-T cell therapy trials were conducted in three centers for treatment of relapsed childhood and adult acute lymphoblastic leukemia (ALL) and revealed an astonishing complete remission rate [101,102,103,104,105,106,107,108].